KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】Cash flow
Market cap
¥188.4B
P/E ratio
67.5x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 2,400 | 2,242 | 1,937 | 2,124 | 2,153 | 2,312 | 2,318 | 2,481 | 2,546 | 2,596 | 2,475 |
| Cash from operations | 14,737 | 27,067 | 15,327 | 21,703 | 21,129 | 27,468 | 14,380 | 13,336 | 9,253 | 2,577 | 29,780 |
| Capital expenditures | -1,954 | -3,124 | -2,166 | -1,689 | -1,908 | -2,159 | -1,973 | -2,986 | -1,987 | -1,861 | -4,138 |
| Cash from investing | 473 | -4,105 | -3,503 | -3,245 | -5,744 | -2,528 | -1,644 | -7,888 | -2,627 | -5,854 | -19,650 |
| Payments for dividends | -4,263 | -5,463 | -6,288 | -6,085 | -6,001 | -5,896 | -5,811 | -5,714 | -5,649 | -5,657 | -7,198 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | -2 | -5,935 |
| Cash from financing | -7,900 | -5,984 | -9,800 | -9,530 | -9,524 | -10,173 | -8,752 | -8,129 | -6,990 | -5,658 | -5,369 |